Article Details

Lumos Pharma (NASDAQ:LUMO) Upgraded to "Buy" at Stifel Nicolaus

Retrieved on: 2021-03-11 12:44:04

Tags for this article:

Click the tags to see associated articles and topics

Lumos Pharma (NASDAQ:LUMO) Upgraded to "Buy" at Stifel Nicolaus. View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 308,812 shares of the company's stock worth $11,028,000 after acquiring an additional 2,700 shares during ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo